Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEGeneral▲ PositiveResults8 Sept 2026

Eyantra Ventures Ltd

41st Annual Report for the financial year 2025-26

Eyantra Ventures Ltd has announced its 41st Annual Report for the financial year 2025-26, showing a strong performance with a 145% year-on-year growth in standalone revenue from operations, and a net revenue of Rs. 67.50 crore. The company reported a net loss of Rs. 475.05 lakh on a consolidated basis due to continued investment-led costs in the IT Services vertical.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change8 Sept 2026

ORTIN GLOBAL LIMITED

ORTIN GLOBAL LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody><tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

ORTIN GLOBAL LIMITED has informed BSE about a change in the designation of its Executive Director.

BSECompany UpdateMgmt Change8 Sept 2026

ORTIN GLOBAL LIMITED

ORTIN GLOBAL LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody><tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

ORTIN GLOBAL LIMITED has informed BSE about a change in the designation of a Non-Executive Non-Independent Director.

BSECompany UpdateMgmt Change8 Sept 2026

ORTIN GLOBAL LIMITED

ORTIN GLOBAL LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

ORTIN GLOBAL LIMITED has informed BSE about the cessation of its Executive Director.

BSECompany UpdateMgmt Change8 Sept 2026

ORTIN GLOBAL LIMITED

ORTIN GLOBAL LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

ORTIN GLOBAL LIMITED has informed BSE about the appointment of an Executive Director.

BSEGeneralResults8 Sept 2026

Megamont Ltd

36th Annual Report of the Company for the Financial Year 2025-26

Megamont Ltd has announced its 36th Annual Report for the Financial Year 2025-26, which includes details of its AGM, financial statements, and statutory reports. The report highlights the company's international trading and supply-chain business, its product portfolios, and its mission to provide reliable sourcing and risk management services to industrial buyers.

Read more →📎 1 attachment
BSEGeneralResults8 Sept 2026

Heera Ispat Ltd

Reg. 34(1) Annual Report

Heera Ispat Ltd has submitted its annual report for 2025-26, including notice of the 34th Annual General Meeting, and has proposed the appointment of Mr. Harshvardhan Katariya as Managing Director and Chairman for a period of five years.

Read more →📎 1 attachment
BSEGeneralResults8 Sept 2026

Aarey Drugs & Pharmaceuticals Ltd

Notice and Integrated Annual Report for 36TH Annual General Meeting of Company as required under Regulation 34(1)

Aarey Drugs & Pharmaceuticals Ltd has announced the Notice and Integrated Annual Report for its 36th Annual General Meeting, scheduled to be held on September 30, 2026. The report includes audited financial statements for the year ended March 31, 2026, and resolutions for the appointment of a director and approval of related party transactions.

Read more →📎 1 attachment
BSECompany Update▲ PositiveRating Change8 Sept 2026

Sun Pharmaceutical Industries Ltd

International Credit Ratings

Sun Pharmaceutical Industries Ltd has been assigned international issuer credit ratings by Moody's and S&P Global, with ratings of Baa1 and BBB+ respectively, reflecting the strength of Sun Pharma's business and financial profile, and taking into account its proposed acquisition of Organon & Co.

Read more →📎 1 attachment
BSEGeneralResults8 Sept 2026

SVA India Ltd

Annual Report for the Financial Year 2025-26.

SVA India Ltd has announced its Annual Report for the Financial Year 2025-26 and Notice convening the 45th Annual General Meeting. The meeting will be held on September 30, 2026, to discuss the audited standalone and consolidated financial statements for the year ended March 31, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults8 Sept 2026

SIP Industries Ltd

SIP Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/09/2026 ,inter alia, to consider and approve 1. The unaudited Financial Results of the Company for the Quarter ended June 30, 2026, along with the Limited Review Report of the Auditors. 2. Any other business with the permission of the Chair.

SIP Industries Ltd has scheduled a Board Meeting on 11/09/2026 to consider and approve the unaudited Financial Results for the Quarter ended June 30, 2026, along with the Limited Review Report of the Auditors.

Read more →📎 1 attachment
BSECompany UpdateAuditor Change8 Sept 2026

NMDC Ltd

As per attachment

NMDC Ltd has informed about the appointment of new statutory auditors and branch auditors as per Regulation 30 of SEBI (LODR) Regulations, 2015.

Read more →📎 1 attachment
BSEGeneralResults8 Sept 2026

Chandni Machines Ltd

Annual Report of the company for the Financial Year 2025-2026

Chandni Machines Ltd has announced its Annual Report for the Financial Year 2025-2026, along with a notice of its 10th Annual General Meeting to be held on September 30, 2026. The report includes the audited standalone financial statements, reports of the Board of Directors and Auditors, and resolutions for the appointment of a director and an independent director.

Read more →📎 1 attachment
BSEGeneralResults8 Sept 2026

Nutraplus India Ltd

Notice of 36th Annual General Meeting and Annual Report for F.Y. 2025-26 pursuant to regulation 34 of SEBI (LODR), Regulations, 2015 as amended

Nutraplus India Ltd has submitted its 36th Annual Report for the financial year 2025-2026, as per Regulation 34 of SEBI (LODR) Regulations, 2015. The report will be considered at the 36th Annual General Meeting scheduled on September 30, 2026. The meeting will also consider the appointment of a director in place of Mr. Mukesh Dhirubhai Naik, who retires by rotation and offers himself for reappointment.

Read more →📎 1 attachment
← PreviousPage 4272 of 7396Next →